Open AccessMP16-02 PHASE III TRIAL OF INTRAVESICAL NADOFARAGENE FIRADENOVEC IN PATIENTS WITH HIGH-GRADE, BCG-UNRESPONSIVE, NON-MUSCLE INVASIVE BLADDER CANCER: TWO YEAR FOLLOW-UP IN THE TA/T1 COHORT
Author(s) -
Yair Lotan,
Anne Schuckman,
Stephen A. Boorjian,
Katherine E. Cilwa,
Colin P.N. Dinney
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002001.02
Subject(s) - medicine , bladder cancer , cohort , cancer , urothelium , urology , carcinoma in situ , oncology , urinary bladder